Imaging bridges a crucial gap in space and time in life science and medicine: from atomic to anatomic objects to whole body imaging, from picoseconds to years in population studies. New molecular and cellular insights are obtained from imaging. These findings should be integrated with data science into a coherent picture of tissues, organs and organisms for early interception of disease. These fundamental developments call for hitherto unavailable research frameworks, international partnership and collaborative culture to promote strong ties across multiple research domains and imaging modalities; connecting nanoscopic views, length scales, time scales and mesoscopic pictures with mechanistic insights and macroscopic function of biological and clinical importance. To meet this goal the Max Delbrück Center for Molecular Medicine; the Weizmann Institute of Science in Rehovot, Israel; the Humboldt University of Berlin and the Charité-University Medicine, Berlin have joined forces to establish a Helmholtz International Research School (HIRS) on imaging from the NAno to the MEso (iNAMES). These efforts are complemented by the Helmholtz Imaging Platform (HIP), with the Max Delbrück Center being a HIP core in collaboration with the DESY Hamburg and DKFZ Heidelberg. iNAMES and HIP are acting as springboards to intensify scientific interactions in imaging, data sciences, information technologies and digital engineering research fields. The field of Magnetic Resonance (MR) has evolved rapidly over the past quarter of a century, allowing for an ever growing number of applications across a broad spectrum of basic, translational and clinical research. One important development which is in the spotlight of MR research is Ultrahigh Field Magnetic Resonance (UHF-MR). The pace of discovery is heartening and a powerful motivator to transfer the lessons learned at ultrahigh fields from basic research into the clinical scenario. These efforts are fueled by the unmet clinical needs and the quest for advancing the capabilities of diagnostic MR imaging – today.
The development of UHF-MR is moving forward at an amazing speed that is breaking through technical barriers almost as fast as they appear. UHF-MR has become an engine for innovation in experimental and clinical research. With more than 60.000,000 MR examinations already performed at 7.0 Tesla, the reasons for moving UHF-MR into clinical applications are more compelling than ever. Images from these instruments have revealed new aspects of the anatomy, functions and physio-metabolic characteristics of the brain, heart, joints, kidneys, liver, eye, and other organs/tissues, at an unparalleled quality. UHF-MR has a staggering number of potential uses in neuroscience, neurology, radiology, neuroradiology, cardiology, internal medicine, oncology, nephrology, ophthalmology and other related clinical fields. As they are developed, we will push the boundaries of MR physics, biomedical engineering and biomedical sciences in many other ways. Realizing these opportunities, we are very much delighted to announce the 11th Annual Scientific Symposium on Clinical Needs, Research Promises and Technical Solutions in Ultrahigh Field MR, which will be held on Friday, September 4th 2020 in Berlin, Germany. Please save the date. The symposium is designed to provide an overview of state-of-the-art (pre)clinical UHF-MR, to discuss the clinical relevance of UHF-MR, to explore future directions of UHF-MR, to foster explorations into ultrahigh field-MR and to initiate local, regional, national and international collaboration and last but not least to provide plenty of time to engage into fruitful exchange with peers and colleagues. The symposium is tailored to attract basic scientists, engineers, hardware professionals, translational researchers, applied scientists and clinicians with all levels of experience and expertise ranging from undergraduate and graduate students interested in imaging to trainees, advanced users and applications experts.
Dr. Timkehet Teffera
phone: +49 30 9406 4255
phone: +49 30 9406 2719